Gilead Sciences, Inc. (GILD)
135.38
+1.65
(+1.23%)
USD |
NASDAQ |
May 27, 11:54
Gilead Sciences Market Cap : 168.08B for May 27, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 183.95B |
| Biogen, Inc. | 29.43B |
| AbbVie, Inc. | 381.17B |
| Moderna, Inc. | 19.07B |
| Johnson & Johnson | 560.62B |
Market Cap Related Metrics
| PE Ratio | 18.42 |
| PS Ratio | 5.700 |
| PEG Ratio | 0.3377 |
| Price to Book Value | 7.148 |
| Price to Free Cash Flow | 16.59 |
| Price | 135.38 |
| Earnings Yield | 5.43% |
| PEGY Ratio | 0.3236 |
| Operating PE Ratio | 14.10 |
| Normalized PE Ratio | 17.55 |